Form 4: Ventyx Biosciences Chief Scientific Officer Sells Shares to Cover Tax Obligations
SEC Form 4
John Nuss, Chief Scientific Officer of Ventyx Biosciences, sold 1,887 shares of common stock on April 2, 2025, to satisfy tax withholding obligations related to vesting restricted stock units.
Summary
- On April 2, 2025, John Nuss, the Chief Scientific Officer of Ventyx Biosciences, sold 1,887 shares of the company's common stock.
- The sale was executed at a price of $1.07 per share.
- This transaction was conducted to cover the reporting person's tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Nuss directly owns 467,226 shares of Ventyx Biosciences.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | Date of the transaction: John Nuss sold 1,887 shares of Ventyx Biosciences common stock. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Ventyx Biosciences, John Nuss, Chief Scientific Officer, Form 4, Share Sale, Tax Obligations, Restricted Stock Units, VTYX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.